Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Exercise dependence induced by pramipexole in Parkinson's Disease-a case report.

Vitale C, Santangelo G, Verde F, Amboni M, Sorrentino G, Grossi D, Barone P.

Mov Disord. 2010 Dec 15;25(16):2893-4. doi: 10.1002/mds.23323. No abstract available.

PMID:
20687190
2.

[Pathological gambling associated with pramipexole use in Parkinson's disease].

Lester J, Gonzalez-Aleman G, Zuniga-Ramirez C, Diaz-Pascuali SP, Raina-Castellino GB, Micheli-Gould F.

Rev Neurol. 2006 Sep 1-15;43(5):316-8. Spanish. No abstract available.

3.

Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease.

Katz KA, Cotsarelis G, Gupta R, Seykora JT.

J Am Acad Dermatol. 2006 Nov;55(5 Suppl):S103-4. No abstract available.

PMID:
17052518
4.

Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.

Perez Lloret S, Rascol O.

Expert Opin Pharmacother. 2010 Sep;11(13):2221-30. doi: 10.1517/14656566.2010.510515. Review.

PMID:
20670197
5.

Impact of pramipexole on the onset of levodopa-related dyskinesias.

Constantinescu R, Romer M, McDermott MP, Kamp C, Kieburtz K; CALM-PD Investigators of the Parkinson Study Group.

Mov Disord. 2007 Jul 15;22(9):1317-9.

PMID:
17534955
6.

Pramipexole and gender identity disorder: expanding the phenotype of hypersexuality in Parkinson's disease.

Odiyoor M, Kobylecki C, Hackett RJ, Silverdale MA, Kellett MW.

Mov Disord. 2009 Dec 15;24(16):2434-5. doi: 10.1002/mds.22848. No abstract available.

PMID:
19891000
7.

[Pathologic gambling as an adverse effect of the treatment for Parkinson's disease].

Miranda M, Slachevsky A, Bustamante L, Pérez C.

Rev Med Chil. 2010 Apr;138(4):521-2. doi: /S0034-98872010000400021. Epub 2010 Jun 30. Spanish. No abstract available.

8.

Pramipexole-induced obsessive-compulsive symptoms in a patient with Parkinson's disease and disgust sensitivity.

Gopalan P, Azzam PN, Hudak R.

Psychosomatics. 2013 May-Jun;54(3):286-9. doi: 10.1016/j.psym.2012.07.001. Epub 2012 Dec 4. No abstract available.

PMID:
23218062
9.

Reversible antecollis associated with pramipexole in a patient with Parkinson's disease.

Kim HJ, Jeon BS, Kim SH, Han SH.

J Clin Neurosci. 2012 Jun;19(6):903-4. doi: 10.1016/j.jocn.2011.09.015. Epub 2012 Feb 20.

PMID:
22353251
10.

[Reversible pathological gambling under treatment with pramipexole].

Spengos K, Grips E, Karachalios G, Tsivgoulis G, Papadimitriou G.

Nervenarzt. 2006 Aug;77(8):958-60. German.

PMID:
16821061
11.

Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.

Parkinson Study Group CALM Cohort Investigators.

Arch Neurol. 2009 May;66(5):563-70. doi: 10.1001/archneur.66.1.nct90001.

PMID:
19433655
12.

Panic attack-like episodes possibly induced by pramipexole in a patient with young-onset Parkinson's disease.

de Cerqueira AC, Nardi AE.

J Neuropsychiatry Clin Neurosci. 2011 Summer;23(3):E21. doi: 10.1176/appi.neuropsych.23.3.E21. No abstract available.

PMID:
21948911
13.

[Mania with psychotic feature induced by the use of pramipexole in Parkinson's disease: a case report].

Meriç C, Pirdoğan E, Günday Toker Ö, Tekin A, Bakım B, Çelik S.

Turk Psikiyatri Derg. 2014 Fall;25(3):212-4. Turkish.

14.

Pramipexole-related chronic lower limb oedema in a patient with Parkinson's disease.

Zavala JA, Munhoz RP, Teive HA.

J Clin Neurosci. 2012 Sep;19(9):1298-9. doi: 10.1016/j.jocn.2011.12.011. Epub 2012 Jun 19.

PMID:
22721884
15.

Text messaging as a new compulsive behavior in a patient with Parkinson's disease.

Ertem DH, Maner F, Koksal A.

Psychiatry Clin Neurosci. 2013 Feb;67(2):126-7. doi: 10.1111/pcn.12015. No abstract available.

16.

Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease.

Hauser RA, Schapira AH, Rascol O, Barone P, Mizuno Y, Salin L, Haaksma M, Juhel N, Poewe W.

Mov Disord. 2010 Nov 15;25(15):2542-9. doi: 10.1002/mds.23317.

PMID:
20669317
17.

Pramipexole-induced psychosis in Parkinson's disease.

Li CT, Tsai SJ, Hwang JP.

Psychiatry Clin Neurosci. 2008 Apr;62(2):245. doi: 10.1111/j.1440-1819.2008.01766.x. No abstract available.

18.

Is there addiction to levodopa in patients with Parkinson's disease?

Merims D, Galili-Mosberg R, Melamed E.

Mov Disord. 2000 Sep;15(5):1014-6. No abstract available.

PMID:
11009217
19.

An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease.

Lyons KE, Pahwa R.

Mov Disord. 2009 Oct 30;24(14):2121-7. doi: 10.1002/mds.22750.

PMID:
19768728
20.

Risk factors for the development of pedal edema in patients using pramipexole.

Kleiner-Fisman G, Fisman DN.

Arch Neurol. 2007 Jun;64(6):820-4. Epub 2007 Apr 9.

PMID:
17420306

Supplemental Content

Support Center